JEOL Ltd. Introduces BioMajesty Series of Clinical Chemistry Analyzers at MEDICA 2019

JEOL Ltd. (Tokyo, Japan) introduced its BioMajesty series of clinical chemistry analyzers featuring unique but proven technologies at this year's MEDICA, the world's largest annual medical technology trade fair, which took place from 18-21 November in Düsseldorf, Germany. At the 2019 edition of MEDICA, more than 5,000 exhibitors from 70 countries presented their newest products and ideas. The event also drew more than 120,000 trade visitors from over 170 countries.

JEOL offers the BioMajesty series of clinical chemistry analyzers which use micro volume of samples and reagents to deliver highly-accurate, high-speed processing through the incorporation of a sample dilution tray, which is an outstanding unique feature of all BioMajesty analyzers.

At the 2019 edition of MEDICA, JEOL showcased its BioMajesty series of clinical chemistry analyzers, which include the JCA-ZS050, JCA-BM6070/C and JCA-BM6010/C. The JCA-ZS050 clinical chemistry analyzer is bolstered by the breakthrough technology and unique dilution mechanism of the series. The JCA-ZS050 boasts of extra-micro-volume measurement with minimum 40μL reaction volume. The 1,800 throughput/hour next-generation chemistry analyzer from JEOL brings innovative operation and simple maintenance, while assuring high-precision data empowered by its novel wash mechanism.

The JCA-BM6070/C clinical chemistry analyzer has 2,400 tests/hour throughput, achieving unprecedented ultrafast processing capability in the 2.0-second cycle time. While realizing minimum reaction volume of 60μl by its unique pre-dilution mechanism, it offers high data reliability and excellent cost benefits.

The JCA-BM6010/C is a compact, reliable chemistry system with versatile functions, offering a maximum throughput of 800 tests/hour for photometry and 1,200 tests/hour with ISE. Bolstered by unique micro-volume technology, a strong tradition of BioMajesty series, it streamlines the daily laboratory routine by automatic on-board hemolysis for HbA1c. The JCA-BM6010/C’s0 superior usability with STAT port and Smart Pause/Smart Start features in its optimized space-saving design help deliver more flexibility.

Related Links:
JEOL Ltd.